Darwin Wealth Management’s Quest Diagnostics DGX Stock Holding History

Darwin Wealth Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Hold	0	–	–	–	655
2020 Q2	–	Sell	-100	Closed	-$8K	–	291
2020 Q1	$8K	Buy	+100	New	+$10.4K	﹤0.01%	511
2017 Q3	–	Sell	-17,658	Closed	-$1.96M	–	105
2017 Q2	$1.96M	Sell	17,658 -1,464	-8%	-$155K	1.08%	32
2017 Q1	$1.88M	Sell	19,122 -486	-2%	-$46.3K	1.09%	41
2016 Q4	$1.8M	Buy	+19,608	New	+$1.69M	1.21%	29

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Darwin Wealth Management's DGX Position: Q2 2026 in Review

Darwin Wealth Management held its Quest Diagnostics (DGX) position steady in Q2 2026 at 0 shares worth $125. The position accounts for ﹤0.01% of the portfolio, ranked #655.

Darwin Wealth Management first reported a position in DGX in Q4 2016 and has held it in 4 quarters since. The position peaked at $1.96M in Q2 2017. 1,107 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

Darwin Wealth Management held 0 shares of Quest Diagnostics worth $125 as of Q2 2026.
Darwin Wealth Management left its Quest Diagnostics share count unchanged in Q2 2026.
Quest Diagnostics made up ﹤0.01% of Darwin Wealth Management's portfolio in Q2 2026, its #655 holding.
Darwin Wealth Management first reported a position in Quest Diagnostics in Q4 2016 and has held it in 4 quarters since.
Darwin Wealth Management's Quest Diagnostics position peaked at $1.96M in Q2 2017.
1,107 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Darwin Wealth Management's 13F filing for Q2 2026, filed 21 Jul 2026.